HEPACAM and myeloid sarcoma: In addition, another study suggested molecular mimicry between EBNA1–a prominent EBV antigen–and GlialCAM (glial cell adhesion molecule), suggesting a direct role of pathogenic antibodies in MS (Lanz et al., 2022).